Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
about
Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunityCD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice.Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Surveillance of cell and tissue perturbation by receptors in the LRC.Protective role of mouse IgG1 in cryoglobulinaemia; insights from an animal model and relevance to human pathology.Mouse and human FcR effector functions.The many faces of FcγRI: implications for therapeutic antibody function.Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammationProtein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.Arthritis models: usefulness and interpretation.Immunoglobulin Glycosylation Effects in Allergy and Immunity.Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.Shp1 function in myeloid cells.Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity.Spontaneous germinal centers and autoimmunity.Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis.Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to InfectionFcεRI γ-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells.B Cell-Extrinsic Myd88 and Fcer1g Negatively Regulate Autoreactive and Normal B Cell Immune Responses.Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis.Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation.Immunoglobulin A as an anti-inflammatory agent
P2860
Q28085328-586D0B6F-48AB-4CCE-BF75-6FC508A0C511Q33426121-1A727D60-864D-4EF0-A491-6DFF5B022CC5Q34499276-E2BF9D9E-F598-4D84-97AB-92F4F5B3AD34Q34499286-E26B13AE-7A01-4047-9241-F7744A37CAA2Q36655657-06A4DDDD-F068-4C4F-9B2B-5DFFC0C6FCFDQ37114367-C942C68B-1638-451C-B8B4-E784D3420892Q38568867-56DA4BC9-F8C3-4FA2-B556-B4063152104CQ38593866-0B213942-2DB0-4619-BB99-1A89FDECB434Q38615349-19BCFCC0-EAEA-4146-BF77-B6B9BB82F42BQ38615362-2FBFD2D5-542E-42D8-8686-5C9E11CE5AC8Q38623017-E6D3CEA8-4090-4403-B2F0-45C6AC244DCEQ38842536-D735A8CA-C47D-4FA9-B1E1-E7E3BFCB60D5Q38872112-998E1748-0C61-4153-9E92-E03A1DD30FBEQ38994739-FD8322D2-A88F-45C2-B681-6E69189A4798Q39260017-295DA2B2-4A76-4BD5-9021-186163D20E78Q39367824-786636E4-0DCD-4FA9-BCC3-09856B2D3201Q40088326-C4F5F5DE-BD01-4F98-BB97-C4B393C736A6Q40343247-25F22493-F787-460E-9E24-623CB751D6F7Q40404277-2C6035CF-2F36-49D5-8C7E-DDC7E4AA230BQ40499631-80C80CDC-D031-4E6A-BAFF-92307D82B8B6Q45365480-C1888282-35E5-48E9-A754-A2E62E7462B3Q48207485-AF96D030-7335-426B-ADBC-0CC18DAAB877Q51141211-D79DD539-D560-47F0-9686-0473D150A4B8Q55325579-BC7CAF75-A420-4933-A982-A092F67E4D3BQ58861400-9631201B-5FD2-4A04-9264-A45D56D0A7F2
P2860
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@ast
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@en
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@nl
type
label
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@ast
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@en
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@nl
prefLabel
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@ast
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@en
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@nl
P2093
P2860
P50
P356
P1476
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
@en
P2093
Elisabetta Rossato
Erwan Boedec
Friederike Jönsson
Gilles Hayem
Jamel El Benna
Jean-Michel Goujon
Pierre Launay
Tarek Boussetta
P2860
P304
P356
10.1172/JCI74572
P407
P577
2014-07-25T00:00:00Z